|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 05, 2016 ) The report provides comprehensive information on the therapeutics under development for Les Laboratoires Servier SAS, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Les Laboratoires Servier SAS and features dormant and discontinued projects.
Publisher's Les Laboratoires Servier SAS Industry report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Les Laboratoires Servier SAS
- The report reviews pipeline therapeutics for Les Laboratoires Servier SAS by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Les Laboratoires Servier SAS therapeutics and enlists all their major and minor projects
- The report assesses Les Laboratoires Servier SAS therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001231640/buying
Reasons to Buy
Evaluate Allergan Plc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Allergan Plc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Allergan Plc's pipeline depth and focus of pipeline therapeutics
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001231640/sample
Table of Content: An Overview
Les Laboratoires Servier SAS Snapshot 6
Les Laboratoires Servier SAS Overview 6
Key Information 6
Key Facts 6
Les Laboratoires Servier SAS - Research and Development Overview 7
Key Therapeutic Areas 7
Les Laboratoires Servier SAS - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Les Laboratoires Servier SAS - Pipeline Products Glance 15
Les Laboratoires Servier SAS - Late Stage Pipeline Products 15
Pre-Registration Products/Combination Treatment Modalities 15
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001231640/discount
Phase III Products/Combination Treatment Modalities 16
Les Laboratoires Servier SAS - Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Phase I Products/Combination Treatment Modalities 18
Les Laboratoires Servier SAS - Early Stage Pipeline Products 19
Preclinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
Les Laboratoires Servier SAS - Drug Profiles 21
(amlodipine besylate + perindopril) 21
Product Description 21
Mechanism of Action 21
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001231640/buy/1500
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
